TNNI3 and familial dilated cardiomyopathy: The maintained force development, the increased Ca2+ sensitivity and lower cTnI phosphorylation are in excellent agreement with the observed alterations in cardiomyocyte function in patients with end‐stage dilated cardiomyopathy (DCM; Hamdani et al., 2008, 2010).